Proposal for fluorescence-based in vitro assay using human and zebrafish monoamine transporters to detect biological activities of antidepressants in wastewater
Authors:
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Science of The Total Environment
- Vol. 770, 144665
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (17H01907)
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of the Environment, Government of Japan
This publication has 50 references indexed in Scilit:
- Active Metabolites as Antidepressant Drugs: The Role of Norquetiapine in the Mechanism of Action of Quetiapine in the Treatment of Mood DisordersFrontiers in Psychiatry, 2013
- Effects of fluoxetine on the swimming and behavioural responses of the Arabian killifishEcotoxicology, 2012
- 4-(4-(Dimethylamino)phenyl)-1-methylpyridinium (APP+) Is a Fluorescent Substrate for the Human Serotonin TransporterJournal of Biological Chemistry, 2012
- Natural versus wastewater derived dissolved organic carbon: Implications for the environmental fate of organic micropollutantsWater Research, 2011
- Does waterborne citalopram affect the aggressive and sexual behaviour of rainbow trout and guppy?Journal of Hazardous Materials, 2011
- Antidepressant Pharmaceuticals in Two U.S. Effluent-Impacted Streams: Occurrence and Fate in Water and Sediment, and Selective Uptake in Fish Neural TissueEnvironmental Science & Technology, 2010
- Differential inhibitory effects of drugs acting at the noradrenaline and 5‐hydroxytryptamine transporters in rat and human neocortical synaptosomes*British Journal of Pharmacology, 2009
- A Combined Assay of Cell Viability and in Vitro Cytotoxicity with a Highly Water-Soluble Tetrazolium Salt, Neutral Red and Crystal Violet.Biological and Pharmaceutical Bulletin, 1996
- Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomesLife Sciences, 1993
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973